Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading research institute is looking for a Postdoctoral Scientist in Cancer Immunology to contribute to groundbreaking research on liver cancer. The role involves project management, technical support, and collaboration in studying the interaction between immune cells and the tumor microenvironment. This is an excellent opportunity for someone passionate about advancing cancer research with a supportive team.
Social network you want to login/join with:
col-narrow-left
The Roger Williams Institute of Liver Studies
slough, United Kingdom
Other
-
Yes
col-narrow-right
3
31.05.2025
15.07.2025
col-wide
Job Title: Postdoctoral Scientist
Reporting to: Dr Luca Urbani, Principal Investigator & Senior Lecturer
Duration: 2-year fixed term contract
Salary: £44,501 per annum, depending on experience
Pension: Minimum employer contribution 8%, increased with higher personal contributions
Location: London, SE5
Hours: Full time, 36.25 hours per week
The Role
The Roger Williams Institute of Liver Studies are seeking an enthusiastic and dynamic new member of staff to join the Liver Regeneration & Tissue Engineering group, at postdoctoral level. The post holder will have responsibility for the day-to-day management and coordination of a project looking at the immunomodulatory properties of the extracellular matrix (ECM) in hepatocellular carcinoma and other liver cancers, in particular the cross-talk between immune cells and specific ECM-associated proteins. A description of the project is available below.
The post holder will provide technical support by helping with lab organisation, conducting research experiments, collecting and analysing data, reviewing the literature, writing reports and manuscripts for publication, and presenting their research at internal and external scientific meetings/conferences. The post holder will be a point of contact for staff and students regarding experimental procedures and techniques for the research area. The post holder will also act as a mentor and supervisor to junior members of the research team and visiting students.
The Roger Williams Institute of Liver Studies is a unique clinical academic partnership between the Foundation for Liver Research, King’s College London and King’s College Hospital that encompasses a multi-disciplinary team focussed on liver research and the improvement of outcomes for patients with liver diseases. This role will be employed by the Foundation for Liver Research, registered charity no. 1134579.
Project Background
The aim of the project is to study the crosstalk between immune cells and the extracellular matrix (ECM) in primary (HCC) and secondary (colon cancer metastasis) liver cancer using patient-derived cells and ECM extracts. The final goal is to understand how the extracellular compartment of the tumour microenvironment can modulate immune cell activity and phenotypes.
The interaction of tumour microenvironment (TME) with cancer cells is closely involved with tumour development, progression and drug resistance. The TME is a complex network composed of multiple non-malignant cells including cancer associated fibroblasts (CAFs), endothelial cells, immune and inflammatory cells and the ECM. The ECM is a dynamic web of molecules that provides structural support and biochemical cues and is fundamental in different tissue processes.
It is well established that liver cancer is associated with profound remodelling of the liver ECM, which becomes stiffer and modulates cell behaviour, tumour progression, metastatic dissemination and immune cell evasion and function. While it is known that the ECM has immunomodulatory properties, the impact of tumour-specific ECM proteins on anti-tumour immune responses is unknown.
Immunotherapy and in particular checkpoint receptor inhibition (CRI) is a promising therapeutic avenue in liver cancer to rescue exhausted and dysfunctional immune cells and restore anti-tumour immunity. However, in HCC response rate is only 20% and many patients are resistant to CRI or become refractory after an initial response. The role of the ECM in response or resistance to CRI in liver cancers in unknown.
Our team has been addressing these issues by combining studies of liver immunology and checkpoint receptors, and the knowledge and technologies in matrix biology of Dr Urbani’s group (Liver Regeneration and Tissue Engineering).
With this project, we aim to determine the immunomodulatory properties of specific cancer ECM proteins in HCC and other liver cancers and their potential role in orchestrating tumour-specific immunity and response to immunotherapy. The project originates from ground-breaking preliminary data collected by the team, which included data from co-cultures of circulating and tissue infiltrating human immune cells and with different ECM-extracts obtained with decellularisation of tissue samples.
These co-cultures will be performed with a larger cohort of samples and pathways identified will be further investigated in co-culture experiments of immune cells with in vitro hepatic stellate cells- or CAF-derived matrix obtained in vitro with established protocols, to better understand mechanisms of interaction of immune cells with the remodelled tumour ECM.
Different techniques will be used to characterise the immune cell response to the different patient derived ECMs and then correlate the findings with in vivo/clinical data. Techniques will include: FACS, Luminex, T cell proliferation assay, proteomics, spatial transcriptomics and proteomics, etc.
In conclusion, we aim to show how individual components of the remodelled ECM in liver cancer can impede anti-tumour immunity and, by identifying therapeutic targets, how these effects might be mitigated. This project could provide a precious body of knowledge about how the ECM shields the tumour from the immune system and may control local response to CRI and could open new therapeutic avenues in treating liver cancer.
Post Specification
The post holder will be responsible for the following:
Specific tasks include:
The post offers an excellent career development opportunity for a laboratory scientist with experience in molecular immunology or cancer immunology. Training will be available and there will be opportunity for the post holder to develop his/her/their own interests within the scope of the project.
The following skills and attributes are required for the post-doctoral position:
Essential skills:
The appointee will be expected to:
In the event that you are invited for interview we will contact you by email confirming the arrangements.
The Roger Williams Institute of Liver Studies and the Foundation for Liver Research are committed to fostering a safe and welcoming working environment where everyone feels valued.